COMy 2016: Highlights from Day 2
Arnon Nagler et al.
The biology of the plasma cell and drug targets in multiple myeloma
Side effects of panobinostat in multiple myeloma
The role of imaging techniques in defining response in multiple myeloma
What is the best treatment regimen for MM?